Patent ID: 7138427
Filing Date: 2006-11-21
Classification: A61P,C07J

Abstract:
1. A method of treating a condition or conditions selected from the group consisting of Alzheimer's disease, senile dementia of the Alzheimer's type (SDAT), Parkinson's disease, Lewi body dementia, postural hypotension, autism, chronic fatigue syndrome, Myasthenia Gravis, and learning deficit and memory loss which comprises administering to a human an effective amount of a sapogenin derivative of general formula (I) or (II): including all stereoisomers and racemic mixtures thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable pro-drug precursor of any of the compounds of general formula (I) or (II), wherein: in the general formula (I): R R R R no double bonds are present the methyl group at C20 is α; and wherein in the general formula (II): R R R R